Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease

Camurati-Engelmann disease (CED, MIM 131300) is an autosomal dominant, progressive diaphyseal dysplasia characterized by hyperosteosis and sclerosis of the diaphyses of long bones. We recently assigned the CED locus to an interval between D19S422 and D19S606 at chromosome 19q13.1–q13.3 (ref. 2), which two other groups confirmed. As the human transforming growth factor-β1 gene (TGFB1) is located within this interval, we considered it a candidate gene for CED.

[1]  David W. Burt,et al.  Evolutionary Origins of the Transforming Growth Factor-β Gene Family , 1992 .

[2]  R. Derynck,et al.  Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7 , 1986, Somatic cell and molecular genetics.

[3]  R. Derynck,et al.  Osteoblastic Responses to TGF-β during Bone Remodeling , 1998 .

[4]  R. Derynck,et al.  Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. , 1999, Development.

[5]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[6]  D. Rifkin,et al.  Latent transforming growth factor-beta: structural features and mechanisms of activation. , 1997, Kidney international.

[7]  Y. Fukushima,et al.  Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3. , 2000, American journal of human genetics.

[8]  I. Leigh,et al.  Growth factors : a practical approach , 1993 .

[9]  S. Blanton,et al.  Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region. , 2000, Genomics.

[10]  R. Gershoni-baruch,et al.  Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13 , 2000, Journal of medical genetics.

[11]  Y. Makita,et al.  Intrafamilial phenotypic variability in Engelmann disease (ED): are ED and Ribbing disease the same entity? , 2000, American journal of medical genetics.

[12]  J. Gunn,et al.  Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.